Check the time stamp on this data. Updated AI-Generated Signals for Mannkind Corporation (MNKD) available here: MNKD.

Watch These Three Value Stocks  In October ...

When a stock breaks out above the 20-day simple moving average, good things could be on the horizon. How should investors react?

Over the last 7 days, the United States market has remained flat, yet it boasts a remarkable 33% increase over the past year with earnings forecasted to grow by 15% annually. In this context of robust ...

MannKind announced top-level 30-week results from its Phase 4 INHALE-3 study comparing inhaled insulin to traditional ...

MannKind's (MNKD) stock surged 73%, driven by its 9% royalty stake in Tyvaso DPI. It has strong liquidity. Click here to see ...

On Monday, MannKind Corp (MNKD) stock saw a modest uptick, ending the day at $6.29 which represents a slight increase of $0.09 or 1.45% from the prior close of $6.2. The stock opened at $6.16 and ...

MannKind (MNKD) reported top-level 30-week results from Phase 4 INHALE-3 study, in which additional patients living with type 1 ...

Check the time stamp on this data. Updated AI-Generated Signals for Mannkind Corporation (MNKD) available here: MNKD.

Discover MannKind Corp's innovative patent for synthesizing N-protected 3,6-aminoalkyl-2,5-diketopiperazines, enhancing organic chemistry and pharmaceutical advancements.

On Friday, MannKind Corp (MNKD) stock saw a decline, ending the day at $6.6 which represents a decrease of $-0.10 or -1.49% from the prior close of $6.7. The stock opened at $6.7 and touched a low of ...